| Literature DB >> 32410337 |
Kaori Yasumura1, Haruhiko Abe1, Yoshinori Iida1, Taishi Kato1, Masayuki Nakamura1, Chieko Toriyama1, Hiroki Nishida1, Akiko Idemoto1, Kazuya Shinouchi1, Tsuyoshi Mishima1, Masaki Awata1, Motoo Date1, Yasunori Ueda1, Masaaki Uematsu1, Yukihiro Koretsune1.
Abstract
AIMS: Nutritional status as well as physical capacity is related to prognosis in patients with heart failure. The purpose of this study was to explore a simple prognostic indicator in patients with acute decompensated heart failure (ADHF) by including both nutritional status and physical capacity. METHODS ANDEntities:
Keywords: Acute decompensated heart failure; Elderly patients; Geriatric nutritional risk index; Simple walking test
Mesh:
Year: 2020 PMID: 32410337 PMCID: PMC7373881 DOI: 10.1002/ehf2.12743
Source DB: PubMed Journal: ESC Heart Fail ISSN: 2055-5822
Figure 1Study population. We divided patients into the three groups: Group G (both nutritional status and physical capacity at discharge were good), Group E (either variable was good), and Group B (both variables were bad).
Patient characteristics
| Variables | Total cohort | GNRI <92 | GNRI ≥92 |
| SWT <200 m | SWT ≥200 m |
|
|---|---|---|---|---|---|---|---|
| ( | ( | ( | ( | ( | |||
| Age (years) | 81 ± 9 | 84 ± 7 | 79 ± 9 | <0.01 | 84 ± 10 | 78 ± 9 | <0.01 |
| Men (%) | 62 | 52 | 68 | 0.02 | 52 | 68 | 0.03 |
| BMI (kg/m2) | 21.5 ± 4.8 | 18.5 ± 2.5 | 24.2 ± 4.7 | <0.01 | 20.5 ± 4.8 | 22.3 ± 4.6 | 0.01 |
| Comorbidities | |||||||
| Atrial fibrillation (%) | 45 | 47 | 42 | 0.49 | 47 | 42 | 0.53 |
| Hypertension (%) | 68 | 59 | 75 | 0.02 | 64 | 70 | 0.35 |
| Diabetes mellitus (%) | 33 | 30 | 36 | 0.35 | 28 | 38 | 0.15 |
| COPD (%) | 9 | 7 | 8 | 0.75 | 13 | 4 | 0.01 |
| DCM (%) | 8 | 7 | 7 | 0.83 | 2 | 11 | 0.02 |
| HCM (%) | 5 | 3 | 7 | 0.17 | 5 | 5 | 0.99 |
| HHD (%) | 37 | 35 | 37 | 0.77 | 30 | 41 | 0.11 |
| ICM (%) | 23 | 19 | 25 | 0.27 | 24 | 21 | 0.59 |
| Valvular disease (%) | 32 | 40 | 23 | 0.01 | 33 | 30 | 0.66 |
| Other (%) | 21 | 21 | 22 | 0.78 | 20 | 22 | 0.71 |
| Medication | |||||||
| ACEi/ARB (%) | 59 | 55 | 61 | 0.45 | 49 | 66 | 0.02 |
| Beta blockers (%) | 66 | 67 | 63 | 0.55 | 55 | 72 | 0.01 |
| Diuretics (%) | 94 | 93 | 93 | 0.96 | 95 | 91 | 0.33 |
| Pimobendan (%) | 25 | 29 | 20 | 0.11 | 30 | 19 | 0.06 |
| Laboratory variables | |||||||
| BNP (pg/mL) | 276 ± 334 | 354 ± 434 | 207 ± 186 | <0.01 | 324 ± 416 | 237 ± 242 | 0.07 |
| Haemoglobin (g/dL) | 11.5 ± 1.9 | 10.7 ± 1.7 | 12.1 ± 1.9 | <0.01 | 11.0 ± 1.9 | 11.9 ± 1.8 | <0.01 |
| Urea (mg/dL) | 32 ± 16 | 32 ± 15 | 32 ± 17 | 0.83 | 33 ± 15 | 31 ± 17 | 0.31 |
| eGFR (mL/min/1.73m2) | 39 ± 17 | 41 ± 18 | 38 ± 17 | 0.15 | 38 ± 18 | 39 ± 19 | 0.79 |
| Sodium (mEq/L) | 139 ± 6 | 138 ± 8 | 139 ± 5 | 0.50 | 139 ± 4 | 138 ± 8 | 0.27 |
| C‐reactive protein (mg/dL) | 0.44 ± 0.71 | 0.59 ± 0.91 | 0.32 ± 0.44 | <0.01 | 0.59 ± 0.89 | 0.31 ± 0.49 | <0.01 |
| Albumin (g/L) | 3.5 ± 0.5 | 3.3 ± 0.40 | 3.8 ± 0.36 | <0.01 | 3.4 ± 0.5 | 3.7 ± 0.4 | <0.01 |
| Lymphocytes (mm3) | 1533 ± 557 | 1373 ± 513 | 1677 ± 558 | <0.01 | 1418 ± 514 | 1628 ± 575 | <0.01 |
| Echocardiography indices | |||||||
| EF (%) | 50 ± 17 | 49 ± 17 | 52 ± 18 | 0.25 | 54 ± 17 | 48 ± 17 | 0.03 |
| LVDd (mm) | 52 ± 9 | 51 ± 9 | 53 ± 9 | 0.32 | 51 ± 10 | 53 ± 8 | 0.09 |
| LVMI (g/m2) | 135 ± 49 | 135 ± 45 | 135 ± 52 | 0.97 | 142 ± 60 | 130 ± 39 | 0.17 |
| RWT | 0.38 ± 0.10 | 0.37 ± 0.10 | 0.39 ± 0.10 | 0.20 | 0.39 ± 0.13 | 0.37 ± 0.07 | 0.37 |
| E/A | 0.96 ± 0.70 | 0.88 ± 0.63 | 1.02 ± 0.77 | 0.39 | 0.81 ± 0.37 | 1.05 ± 0.84 | 0.12 |
| E/E' | 17 ± 8 | 17 ± 8 | 17 ± 7 | 0.81 | 19 ± 8 | 16 ± 7 | 0.08 |
| TrPG (mmHg) | 30 ± 12 | 29 ± 10 | 31 ± 14 | 0.31 | 32 ± 11 | 29 ± 13 | 0.33 |
| Prior HF hospitalizations (≥3 times) (%) | 37 | 41 | 34 | 0.30 | 49 | 27 | <0.01 |
ACEi, angiotensin‐converting‐enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; BNP, brain natriuretic peptide; COPD, chronic obstructive pulmonary disease; DCM, dilated cardiomyopathy; EF, ejection fraction; eGFR, estimate glomerular filtration rate; GNRI, geriatric nutritional risk index; HCM, hypertrophic cardiomyopathy; HF, heart failure; HHD, hypertensive heart failure; ICM, ischemic cardiomyopathy; LVDd, left ventricular end diastolic diameter; LVMI, left ventricular mass index; RWT, relative wall thickness; SWT, simple walking test.
Passing the activity level on the simple walking test
|
| Age (years) | Men (%) | GNRI | EF (%) | Hb (g/dL) | |
|---|---|---|---|---|---|---|
| Walking within room | 10 | 88 ± 4 | 20 | 76 ± 9 | 47 ± 17 | 10.9 ± 3.2 |
| Walking within 50 m | 17 | 86 ± 7 | 53 | 87 ± 10 | 55 ± 15 | 10.9 ± 1.7 |
| Walking within 100 m | 23 | 85 ± 7 | 52 | 94 ± 13 | 54 ± 22 | 10.7 ± 1.4 |
| Walking within 200 m | 42 | 84 ± 7 | 60 | 92 ± 12 | 54 ± 15 | 11.2 ± 1.9 |
| Walking over 200 m | 111 | 78 ± 9 | 68 | 97 ± 11 | 48 ± 17 | 11.9 ± 1.8 |
GNRI, geriatric nutritional risk index; EF, ejection fraction; Hb, haemoglobin..
Univariable and multivariable Cox hazard model for mortality
| Univariable analysis | Multivariable analysis | |||
|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| |
| Age (years) | 1.071 (1.033–1.109) | <0.01 | 1.024 (0.979–1.072) | 0.31 |
| BNP (pg/mL) | 1.001 (1.000–1.001) | <0.01 | 1.001 (0.999–1.001) | 0.13 |
| Haemoglobin (g/dL) | 0.803 (0.695–0.928) | <0.01 | 0.954 (0.811–1.123) | 0.57 |
| C‐reactive protein (mg/dL) | 1.310 (0.980–1.751) | 0.07 | 1.144 (0.839–1.561) | 0.39 |
| combined index (GNRI + SWT) | 3.005 (2.051–4.404) | <0.0001 | 2.249 (1.362–3.716) | <0.01 |
BNP, brain natriuretic peptide; CI, confidence interval; GNRI, geriatric nutritional risk index; HR, hazard ratio; SWT, simple walking test.
Cox hazard model for mortality and heart failure rehospitalization
| Univariable analysis | Multivariable analysis | |||
|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| |
| Mortality ( | ||||
| GNRI < 92 at admission | 2.448 (1.442–4.157) | 0.001 | 1.538 (0.823–2.875) | 0.18 |
| GNRI < 92 at discharge | 3.382 (1.900–6.020) | <0.0001 | 2.370 (1.166–4.814) | 0.02 |
| SWT < 200 m | 3.303 (1.905–5.727) | <0.0001 | 1.990 (0.999–3.962) | 0.05 |
| Combined index (GNRI + SWT) | 3.005 (2.051–4.404) | <0.0001 | 2.249 (1.362–3.716) | <0.01 |
| Rehospitalization ( | ||||
| GNRI < 92 at admission | 0.776 (0.518–1.161) | 0.22 | 0.585 (0.362–0.946) | 0.03 |
| GNRI < 92 at discharge | 0.702 (0.483–1.020) | 0.06 | 0.431 (0.266–0.698) | <0.01 |
| SWT < 200 m | 1.047 (0.724–1.515) | 0.81 | 0.950 (0.617–1.464) | 0.82 |
| Combined index (GNRI + SWT) | 0.859 (0.660–1.118) | 0.26 | 0.673 (0.488–0.927) | 0.02 |
The multivariable analysis model included age, brain natriuretic peptide, haemoglobin and C‐reactive protein.
BNP, brain natriuretic peptide; CI, confidence interval; GNRI, geriatric nutritional risk index; HR, hazard ratio; SWT, simple walking test.
Figure 2Kaplan–Meier curves for survival probability among the three groups. Group G, both nutritional status and physical capacity at discharge were good; Group E, either variable was good; Group B, both variables were bad.